Bookshelf
| can't find it |

| browse books |
books
 

| book details |

Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary

By (author) Forum on Neuroscience and Nervous System Disorders, By (author) Board on Health Sciences Policy, By (author) Institute of Medicine, Edited by Bruce M. Altevogt, Edited by Miriam Davis, Edited by Diana E. Pankevich

| on special |

normal price: R 775.95

Price: R 736.95


| book description |

Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, currently exist for measuring glutamate pathology in CNS disorders or injuries. Glutamate dysfunction has been associated with an extensive range of nervous system diseases and disorders. Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer's, substance abuse, and traumatic brain injury. These conditions are widespread, affecting a large portion of the United States population, and remain difficult to treat. Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers. The Institute of Medicine's Forum on Neuroscience and Nervous System Disorders held a workshop on June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of such biomarkers. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary investigates promising current and emerging technologies, and outlines strategies to procure resources and tools to advance drug development for associated nervous system disorders. Moreover, this report highlights presentations by expert panelists, and the open panel discussions that occurred during the workshop.

| product details |



Normally shipped | This title will take longer to obtain, and should be delivered in 6-8 weeks
Publisher | National Academies Press
Published date | 5 Aug 2011
Language |
Format | Paperback / softback
Pages | 74
Dimensions | 229 x 152 x 0mm (L x W x H)
Weight | 0g
ISBN | 978-0-3092-1221-2
Readership Age |
BISAC | medical / neurology


| other options |



Normally shipped | Usually dispatched in 3 to 4 weeks as supplier is out of stock
Readership Age |
Normal Price | R 880.95
Price | R 836.95 | on special |



| your trolley |

To view the items in your trolley please sign in.

| sign in |

| specials |

The Silent Patient: The record-breaking, multimillion copy Sunday Times bestselling thriller and TikTok sensation

Alex Michaelides
Paperback / softback
352 pages
was: R 280.95
now: R 252.95
Available from overseas. Dispatched in aprox 4-8 weeks as local supplier is out of stock

With film rights snapped up by an Oscar winning Hollywood production company, rights sold in a world record 43 territories, and rave blurbs from David Baldacci, Lee Child and A.

The Thing at 52

Mr. Ross Montgomery
Hardback
40 pages
was: R 363.95
now: R 345.95
Usually dispatched in 3 to 4 weeks as supplier is out of stock

The Thing at 52 is a beautiful picture book about friendship, loneliness and learning how to say goodbye.

Free Your Mind: The new world of manipulation and how to resist it

Laura Dodsworth
Paperback / softback
384 pages
was: R 300.95
now: R 270.95
Available from overseas. Dispatched in aprox 4-8 weeks as local supplier is out of stock

The Instant Sunday Times Bestseller Learn how to recognise and resist the daily attempts to control and manipulate your mind.